Current Problems in Cardiology
Volume 33, Issue 9 , Pages 467-546 , September 2008

Supraventricular Tachycardia—Part I

References 

  1. Durrer D, Schoo L, Schuilenburg RM, et al. The role of premature beats in the initiation and the termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome. Circulation. 1967;36(5):644–662
  2. Coumel P, Cabrol C, Fabiato A, et al. Tachycardie permanente par rhythme reciproque. Arch Mal Coeur. 1967;60:1830–1845
  3. Wellens HJ. Electrical Stimulation of the Heart in the Study and Treatment of Tachycardias. Baltimore, MD: University Park Press; 1971;
  4. Scherlag BJ, Lau SH, Helfant RH, et al. Catheter technique for recording His bundle activity in man. Circulation. 1969;39(1):13–18
  5. Cobb FR, Blumenschein SD, Sealy WC, et al. Successful surgical interruption of the bundle of Kent in a patient with Wolff-Parkinson-White syndrome. Circulation. 1968;38(6):1018–1029
  6. Scheinman MM, Morady F, Hess DS, et al. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA. 1982;248(7):851–855
  7. Josephson ME. Clinical Cardiac Electrophysiology: Techniques and Interpretations. 3rd edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2002;
  8. Jackman WM, Wang XZ, Friday KJ, et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. New Engl J Med. 1991;324(23):1605–1611
  9. Darbar D, Olgin JE, Miller JM, et al. Localization of the origin of arrhythmias for ablation: from electrocardiography to advanced endocardial mapping systems. J Cardiovasc Electrophysiol. 2001;12(11):1309–1325
  10. Kottkamp H, Hindricks G, Breithardt G, et al. Three-dimensional electromagnetic catheter technology: electroanatomical mapping of the right atrium and ablation of ectopic atrial tachycardia. J Cardiovasc Electrophysiol. 1997;8(12):1332–1337
  11. Cotton RP. Notes and observation upon a case of unusually rapid action of the heart (232 per minute). BMJ. 1867;1:629–630
  12. Bristowe JS. On recurrent palpitations of extreme rapidity in persons otherwise apparenty healthy. Brain. 1887;10:164–198
  13. Major RH. Classic Description Disease. Springfield, IL: Charles C. Thomas; 1945;
  14. Hoffman A. Paroxysmal Tachycardie. Wiesbaden, Germany: JF Bergmann; 1900;
  15. Lewis T. Paroxysmal tachycardia. Heart (Br Cardiac Soc). 1909;1:43–72
  16. Mines GR. On dynamic equilibrium in the heart. J Physiol. 1913;46:349–383
  17. Waldo AL, Wit AL. Mechanisms of cardiac arrhythmias. Lancet. 1993;341(8854):1189–1193
  18. Orejarena LA, Vidaillet H, DeStefano F, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998;31(1):150–157
  19. U.S. Department of Health & Human Services (DHHS): Centers for Disease Control Vital and Health Statistics. National Hospital Discharge Survey: annual summary with detailed diagnosis and procedure data (1999). DHHS Publication No. (PHS) 2001-1722, 2001.
  20. Porter MJ, Morton JB, Denman R, et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm. 2004;1(4):393–396
  21. Ko JK, Deal BJ, Strasburger JF, et al. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992;69(12):1028–1032
  22. Rodriguez LM, de Chillou C, Schlapfer J, et al. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol. 1992;70(13):1213–1215
  23. Goyal R, Zivin A, Souza J, et al. Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia. Am Heart J. 1996;132(4):765–767
  24. Nattel S. Age, gender, and supraventricular arrhythmias: roles of ion channels, connexins, and tissue architecture?. Heart Rhythm. 2004;1(4):397–398
  25. Clair WK, Wilkinson WE, McCarthy EA, et al. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients. Circulation. 1993;87(4):1114–1122
  26. Manolio TA, Furberg CD, Rautaharju PM, et al. Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the Cardiovascular Health Study. J Am Coll Cardiol. 1994;23(4):916–925
  27. Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest. 1982;81(3):302–307
  28. Kantelip JP, Sage E, Duchene-Marullaz P. Findings on ambulatory electrocardiographic monitoring in subjects older than 80 years. Am J Cardiol. 1986;57(6):398–401
  29. Aronow WS, Epstein S, Schwartz KS, et al. Correlation of complex ventricular arrhythmias detected by ambulatory electrocardiographic monitoring with echocardiographic left ventricular hypertrophy in persons older than 62 years in a long-term health care facility. Am J Cardiol. 1987;60(8):730–732
  30. Wellens HJJ. The electrophysiologic properties of the accessory pathway in the Wolff-Parkinson-White syndrome. In:  Wellens HJJ,  Kie KI,  Janse MJ editor. The Conduction System of the Heart. Leiden, The Netherlands: HE Stenfert Kroese B.V; 1976;p. 567–588
  31. Guize L, Soria R, Chaouat JC, et al. Prevalence and course of Wolf-Parkinson-White syndrome in a population of 138,048 subjects. Ann Med Interne (Paris). 1985;136(6):474–478
  32. Munger TM, Packer DL, Hammill SC, et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation. 1993;87(3):866–873
  33. Wellens HJ, Bar FW, Farre J, et al. Diagnosis and incidence of concealed accessory pathways in patients suffering from paroxysmal AV junctional tachycardias. Rev Lat Cardiol. 1980;1:60–67
  34. Montoya PT, Brugada P, Smeets J, et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J. 1991;12(2):144–150
  35. Timmermans C, Smeets JL, Rodriguez LM, et al. Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1995;76(7):492–494
  36. Vidaillet HJ, Pressley JC, Henke E, et al. Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). New Engl J Med. 1987;317(2):65–69
  37. Harnischfeger WW. Hereditary occurrence of the pre-excitation (Wolff-Parkinson-White) syndrome with re-entry mechanism and concealed conduction. Circulation. 1959;19(1):28–40
  38. Vidaillet HJ, Burton CS, Ramirez NM, et al. An unusual variant of familial preexcitation. Am J Cardiol. 1987;59(4):371–373
  39. Gollob MH, Seger JJ, Gollob TN, et al. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation. 2001;104(25):3030–3033
  40. Gollob MH, Green MS, Tang AS, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. New Engl J Med. 2001;344(24):1823–1831
  41. Katz LN, Pick A. Clinical electrocardiography. Part I. The Arrhythmias. In: Philadephia, PA: Lea & Febiger; 1956;p. 275–381
  42. Wood KA, Drew BJ, Scheinman MM. Frequency of disabling symptoms in supraventricular tachycardia. Am J Cardiol. 1997;79(2):145–149
  43. Klein GJ, Bashore TM, Sellers TD, et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med. 1979;301(20):1080–1085
  44. Wang YS, Scheinman MM, Chien WW, et al. Patients with supraventricular tachycardia presenting with aborted sudden death: incidence, mechanism and long-term follow-up. J Am Coll Cardiol. 1991;18(7):1711–1719
  45. Hays LJ, Lerman BB, DiMarco JP. Nonventricular arrhythmias as precursors of ventricular fibrillation in patients with out-of-hospital cardiac arrest. Am Heart J. 1989;118(1):53–57
  46. Getchell WS, Larsen GC, Morris CD, et al. Epidemiology of syncope in hospitalized patients. J Gen Intern Med. 1999;14(11):677–687
  47. Baine WB, Yu W, Weis KA. Trends and outcomes in the hospitalization of older Americans for cardiac conduction disorders or arrhythmias, 1991-1998. J Am Geriatr Soc. 2001;49(6):763–770
  48. Tikkanen I, Metsarinne K, Fyhrquist F. Atrial natriuretic peptide in paroxysmal supraventricular tachycardia. Lancet. 1985;2(8445):40–41
  49. Leitch JW, Klein GJ, Yee R, et al. Syncope associated with supraventricular tachycardia (An expression of tachycardia rate or vasomotor response?). Circulation. 1992;85(3):1064–1071
  50. Cruz FE, Cheriex EC, Smeets JL, et al. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol. 1990;16(3):739–744
  51. Shinbane JS, Wood MA, Jensen DN, et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 1997;29(4):709–715
  52. McLaran CJ, Gersh BJ, Sugrue DD, et al. Tachycardia induced myocardial dysfunction (A reversible phenomenon?). Br Heart J. 1985;53(3):323–327
  53. Morady F, Krol RB, Nostrant TT, et al. Supraventricular tachycardia induced by swallowing: a case report and review of the literature. Pacing Clin Electrophysiol. 1987;10(1 Pt. 1):133–138
  54. Falk RH, Tarko HB, Levine PA. Positional supraventricular tachycardia. N Engl J Med. 1981;304(22):1364
  55. Luria MH. Selected clinical features of paroxysmal tachycardia: a prospective study in 120 patients. Br Heart J. 1971;33:351–357
  56. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79(4):733–743
  57. Levine RL, Pepe PE, Fromm RE, et al. Prospective evidence of a circadian rhythm for out-of-hospital cardiac arrests. JAMA. 1992;267(21):2935–2937
  58. Irwin JM, McCarthy EA, Wilkinson WE, et al. Circadian occurrence of symptomatic paroxysmal supraventricular tachycardia in untreated patients. Circulation. 1988;77(2):298–300
  59. Lee SH, Chang PC, Hung HF, et al. Circadian variation of paroxysmal supraventricular tachycardia. Chest. 1999;115(3):674–678
  60. Rostagno C, Taddei T, Paladini B, et al. The onset of symptomatic atrial fibrillation and paroxysmal supraventricular tachycardia is characterized by different circadian rhythms. Am J Cardiol. 1993;71(5):453–455
  61. Waxman MB, Sharma AD, Cameron DA, et al. Reflex mechanisms responsible for early spontaneous termination of paroxysmal supraventricular tachycardia. Am J Cardiol. 1982;49(2):259–272
  62. Waxman MB, Wald RW, Cameron D. Interactions between the autonomic nervous system and tachycardias in man. Cardiol Clin. 1983;1(2):143–185
  63. Gursoy S, Steurer G, Brugada J, et al. Brief report: the hemodynamic mechanism of pounding in the neck in atrioventricular nodal reentrant tachycardia. N Engl J Med. 1992;327(11):772–774
  64. Goldreyer BN, Kastor JA, Kershbaum KL. The hemodynamic effects of induced supraventricular tachycardia in man. Circulation. 1976;54(5):783–789
  65. Kapoor WN, Karpf M, Wieand S, et al. A prospective evaluation and follow-up of patients with syncope. N Engl J Med. 1983;309(4):197–204
  66. Wellens HJ, Bar FW, Lie KI. The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med. 1978;64(1):27–33
  67. Stewart RB, Bardy GH, Greene HL. Wide complex tachycardia: misdiagnosis and outcome after emergent therapy. Ann Intern Med. 1986;104(6):766–771
  68. Buxton AE, Marchlinski FE, Doherty JU, et al. Hazards of intravenous verapamil for sustained ventricular tachycardia. Am J Cardiol. 1987;59(12):1107–1110
  69. Lee KW, Yang Y, Scheinman MM. Atrial flutter: a review of its history, mechanisms, clinical features, and current therapy. Curr Probl Cardiol. 2005;30(3):121–167
  70. Hersi A, Wyse DG. Management of atrial fibrillation. Curr Probl Cardiol. 2005;30(4):175–233
  71. Riley MJ, Marrouche NF. Ablation of atrial fibrillation. Curr Probl Cardiol. 2006;31(5):361–390
  72. Janse MJ, Anderson RH, McGuire MA, et al. “AV nodal” reentry: Part I: “AV nodal” reentry revisited. J Cardiovasc Electrophysiol. 1993;4(5):561–572
  73. McGuire MA, Janse MJ, Ross DL. “AV nodal” reentry: Part II: AV nodal, AV junctional, or atrionodal reentry?. J Cardiovasc Electrophysiol. 1993;4(5):573–586
  74. Scheinman MM, Yang Y. The history of AV nodal reentry. Pacing Clin Electrophysiol. 2005;28(11):1232–1237
  75. Iliescu CC, Sebastiani A. Notes on the effects of quinidine upon paroxysms of tachycardia. Heart (Br Cardiac Soc). 1923;10:223–230
  76. Barker PS, Wilson FN, Johnston FD. The mechanism of auricular paroxysmal tachycardia. Am Heart J. 1943;26:435–445
  77. Moe GK, Preston JB, Burlington H. Physiologic evidence for a dual A-V transmission system. Circ Res. 1956;4(4):357–375
  78. Mendez C, Moe GK. Demonstration of a dual A-V nodal conduction system in the isolated rabbit heart. Circ Res. 1966;19(2):378–393
  79. Goldreyer BN, Bigger JT. Site of reentry in paroxysmal supraventricular tachycardia in man. Circulation. 1971;43(1):15–26
  80. Goldreyer BN, Damato AN. The essential role of atrioventricular conduction delay in the initiation of paroxysmal supraventricular tachycardia. Circulation. 1971;43(5):679–687
  81. Denes P, Wu D, Dhingra RC, et al. Demonstration of dual A-V nodal pathways in patients with paroxysmal supraventricular tachycardia. Circulation. 1973;48(3):549–555
  82. Rosen KM, Mehta A, Miller RA. Demonstration of dual atrioventricular nodal pathways in man. Am J Cardiol. 1974;33(2):291–294
  83. Wu D, Denes P, Amat YLF, et al. An unusual variety of atrioventricular nodal re-entry due to retrograde dual atrioventricular nodal pathways. Circulation. 1977;56(1):50–59
  84. Akhtar M, Damato AN, Ruskin JN, et al. Antegrade and retrograde conduction characteristics in three patterns of paroxysmal atrioventricular junctional reentrant tachycardia. Am Heart J. 1978;95(1):22–42
  85. Lev M, Widran J, Erickson EE. A method for the histopathologic study of the atrioventricular node, bundle, and branches. AMA Arch Pathol. 1951;52(1):73–83
  86. Widran J, Lev M. The dissection of the atrioventricular node, bundle and bundle branches in the human heart. Circulation. 1951;4(6):863–867
  87. Anderson RH, Ho SY. The architecture of the sinus node, the atrioventricular conduction axis, and the internodal atrial myocardium. J Cardiovasc Electrophysiol. 1998;9(11):1233–1248
  88. McGuire MA, Robotin M, Yip AS, et al. Electrophysiologic and histologic effects of dissection of the connections between the atrium and posterior part of the atrioventricular node. J Am Coll Cardiol. 1994;23(3):693–701
  89. Gonzalez MD, Contreras LJ, Cardona F, et al. Demonstration of a left atrial input to the atrioventricular node in humans. Circulation. 2002;106(23):2930–2934
  90. Keim S, Werner P, Jazayeri M, et al. Localization of the fast and slow pathways in atrioventricular nodal reentrant tachycardia by intraoperative ice mapping. Circulation. 1992;86(3):919–925
  91. Belhassen B, Fish R, Glikson M, et al. Noninvasive diagnosis of dual AV node physiology in patients with AV nodal reentrant tachycardia by administration of adenosine-5′-triphosphate during sinus rhythm. Circulation. 1998;98(1):47–53
  92. Sung RJ, Styperek JL, Myerburg RJ, et al. Initiation of two distinct forms of atrioventricular nodal reentrant tachycardia during programmed ventricular stimulation in man. Am J Cardiol. 1978;42(3):404–415
  93. Donegan CK, Townsend CV. Phenylephrine hydrochloride in paroxysmal supraventricular tachycardia. J Am Med Assoc. 1955;157(9):716–718
  94. Hariman RJ, Gomes JA, El-Sherif N. Catecholamine-dependent atrioventricular nodal reentrant tachycardia. Circulation. 1983;67(3):681–686
  95. Wu D, Denes P, Bauernfeind R, et al. Effects of atropine on induction and maintenance of atrioventricular nodal reentrant tachycardia. Circulation. 1979;59(4):779–788
  96. Hatzinikolaou H, Rodriguez LM, Smeets JL, et al. Isoprenaline and inducibility of atrioventricular nodal re-entrant tachycardia. Heart (Br Cardiac Soc). 1998;79(2):165–168
  97. Yu WC, Chen SA, Chiang CE, et al. Effects of isoproterenol in facilitating induction of slow-fast atrioventricular nodal reentrant tachycardia. Am J Cardiol. 1996;78(11):1299–1302
  98. Kadish AH, Morady F. The response of paroxysmal supraventricular tachycardia to overdrive atrial and ventricular pacing: can it help determine the tachycardia mechanism?. J Cardiovasc Electrophysiol. 1993;4(3):239–252
  99. Kay GN, Epstein AE, Dailey SM, et al. Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia (Evidence for involvement of perinodal myocardium within the reentrant circuit). Circulation. 1992;85(5):1675–1688
  100. Haissaguerre M, Gaita F, Fischer B, et al. Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy. Circulation. 1992;85(6):2162–2175
  101. Lee MA, Morady F, Kadish A, et al. Catheter modification of the atrioventricular junction with radiofrequency energy for control of atrioventricular nodal reentry tachycardia. Circulation. 1991;83(3):827–835
  102. Thapar MK, Gillette PC. Dual atrioventricular nodal pathways: a common electrophysiologic response in children. Circulation. 1979;60(6):1369–1374
  103. Brooks R, Goldberger J, Kadish A. Extended protocol for demonstration of dual AV nodal physiology. Pacing Clin Electrophysiol. 1993;16(2):277–284
  104. Bissett JK, de Soynza N, Kane JJ, et al. Atrioventricular conduction patterns in patients with paroxysmal supraventricular tachycardia. Am Heart J. 1976;91(3):287–291
  105. Denes P, Wu D, Dhingra R, et al. Dual atrioventricular nodal pathways (A common electrophysiological response). Br Heart J. 1975;37(10):1069–1076
  106. Levites R, Haft JI. Evidence suggesting dual A-V nodal pathways in patients without supraventricular tachycardias. Chest. 1975;67(1):36–42
  107. Mitrani RD, Klein LS, Hackett FK, et al. Radiofrequency ablation for atrioventricular node reentrant tachycardia: comparison between fast (anterior) and slow (posterior) pathway ablation. J Am Coll Cardiol. 1993;21(2):432–441
  108. Lindsay BD, Chung MK, Gamache MC, et al. Therapeutic end points for the treatment of atrioventricular node reentrant tachycardia by catheter-guided radiofrequency current. J Am Coll Cardiol. 1993;22(3):733–740
  109. Heidbuchel H, Jackman WM. Characterization of subforms of AV nodal reentrant tachycardia. Europace. 2004;6(4):316–329
  110. Lockwood D, Otomo K, Wang Z, et al. Electrophysiologic characteristics of atrioventricular nodal reentrant tachycardia: implications for the reentrant circuits. In:  Zipes DP,  Jalife J editor. Cardiac Electrophysiology: From Cell to Bedside. 3rd edition. Philadelphia, PA: Saunders; 2004;p. 537–557
  111. Benditt DG, Pritchett EL, Smith WM, et al. Ventriculoatrial intervals: diagnostic use in paroxysmal supraventricular tachycardia. Ann Intern Med. 1979;91(2):161–166
  112. Hwang C, Martin DJ, Goodman JS, et al. Atypical atrioventricular node reciprocating tachycardia masquerading as tachycardia using a left-sided accessory pathway. J Am Coll Cardiol. 1997;30(1):218–225
  113. Goldberger J, Brooks R, Kadish A. Physiology of “atypical” atrioventricular junctional reentrant tachycardia occurring following radiofrequency catheter modification of the atrioventricular node. Pacing Clin Electrophysiol. 1992;15(12):2270–2282
  114. Engelstein ED, Stein KM, Markowitz SM, et al. Posterior fast atrioventricular node pathways: implications for radiofrequency catheter ablation of atrioventricular node reentrant tachycardia. J Am Coll Cardiol. 1996;27(5):1098–1105
  115. Nawata H, Yamamoto N, Hirao K, et al. Heterogeneity of anterograde fast-pathway and retrograde slow-pathway conduction patterns in patients with the fast-slow form of atrioventricular nodal reentrant tachycardia: electrophysiologic and electrocardiographic considerations. J Am Coll Cardiol. 1998;32(6):1731–1740
  116. Delise P, Bonso A, Coro L, et al. Pacemapping of the triangle of Koch: a simple method to reduce the risk of atrioventricular block during radiofrequency ablation of atrioventricular node reentrant tachycardia. Pacing Clin Electrophysiol. 2001;24(12):1725–1731
  117. Delise P, Sitta N, Bonso A, et al. Pace mapping of Koch's triangle reduces risk of atrioventricular block during ablation of atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol. 2005;16(1):30–35
  118. Chen J, Anselme F, Smith TW, et al. Standard right atrial ablation is effective for atrioventricular nodal reentry with earliest activation in the coronary sinus. J Cardiovasc Electrophysiol. 2004;15(1):2–7
  119. Moe GK, Mendez C. The physiologic basis of reciprocal rhythm. Prog Cardiovasc Dis. 1966;8(5):461–482
  120. Miller JM, Rosenthal ME, Vassallo JA, et al. Atrioventricular nodal reentrant tachycardia: studies on upper and lower ‘common pathways’. Circulation. 1987;75(5):930–940
  121. Heidbuchel H, Ector H, Van de Werf F. Prospective evaluation of the length of the lower common pathway in the differential diagnosis of various forms of AV nodal reentrant tachycardia. Pacing Clin Electrophysiol. 1998;21(1 Pt. 2):209–216
  122. Portillo B, Mejias J, Leon-Portillo N, et al. Entrainment of atrioventricular nodal reentrant tachycardias during overdrive pacing from high right atrium and coronary sinus (With special reference to atrioventricular dissociation and 2:1 retrograde block during tachycardias). Am J Cardiol. 1984;53(11):1570–1576
  123. Ross DL, Brugada P, Bar FW, et al. Comparison of right and left atrial stimulation in demonstration of dual atrioventricular nodal pathways and induction of intranodal reentry. Circulation. 1981;64(5):1051–1058
  124. McGuire MA, Lau KC, Johnson DC, et al. Patients with two types of atrioventricular junctional (AV nodal) reentrant tachycardia (Evidence that a common pathway of nodal tissue is not present above the reentrant circuit). Circulation. 1991;83(4):1232–1246
  125. Otomo K, Okamura H, Noda T, et al. “Left-variant” atypical atrioventricular nodal reentrant tachycardia: electrophysiological characteristics and effect of slow pathway ablation within coronary sinus. J Cardiovasc Electrophysiol. 2006;17(11):1177–1183
  126. Waxman MB, Wald RW, Sharma AD, et al. Vagal techniques for termination of paroxysmal supraventricular tachycardia. Am J Cardiol. 1980;46(4):655–664
  127. Waxman MB, Bonet JF, Finley JP, et al. Effects of respiration and posture on paroxysmal supraventricular tachycardia. Circulation. 1980;62(5):1011–1020
  128. Rinkenberger RL, Prystowsky EN, Heger JJ, et al. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation. 1980;62(5):996–1010
  129. DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil (Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group). Ann Intern Med. 1990;113(2):104–110
  130. Huycke EC, Sung RJ, Dias VC, et al. Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study. J Am Coll Cardiol. 1989;13(3):538–544
  131. Basta M, Klein GJ, Yee R, et al. Current role of pharmacologic therapy for patients with paroxysmal supraventricular tachycardia. Cardiol Clin. 1997;15(4):587–597
  132. Margolis B, DeSilva RA, Lown B. Episodic drug treatment in the management of paroxysmal arrhythmias. Am J Cardiol. 1980;45(3):621–626
  133. Yeh SJ, Kou HC, Lin FC, et al. Effects of oral diltiazem in paroxysmal supraventricular tachycardia. Am J Cardiol. 1983;52(3):271–278
  134. Schuger CD, Steinman RT, Meissner MD, et al. Clinical management of patients with atrioventricular nodal reentrant tachycardia. Cardiol Clin. 1990;8(3):491–501
  135. Epstein LM, Scheinman MM, Langberg JJ, et al. Percutaneous catheter modification of the atrioventricular node (A potential cure for atrioventricular nodal reentrant tachycardia). Circulation. 1989;80(4):757–768
  136. Jazayeri MR, Hempe SL, Sra JS, et al. Selective transcatheter ablation of the fast and slow pathways using radiofrequency energy in patients with atrioventricular nodal reentrant tachycardia. Circulation. 1992;85(4):1318–1328
  137. Langberg JJ, Leon A, Borganelli M, et al. A randomized, prospective comparison of anterior and posterior approaches to radiofrequency catheter ablation of atrioventricular nodal reentry tachycardia. Circulation. 1993;87(5):1551–1556
  138. Langberg JJ, Kim YN, Goyal R, et al. Conversion of typical to “atypical” atrioventricular nodal reentrant tachycardia after radiofrequency catheter modification of the atrioventricular junction. Am J Cardiol. 1992;69(5):503–508
  139. Jackman WM, Beckman KJ, McClelland JH, et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med. 1992;327(5):313–318
  140. Morady F. Catheter ablation of supraventricular arrhythmias: state of the art. Pacing Clin Electrophysiol. 2004;27(1):125–142
  141. Heidbuchel H. How to ablate typical `slow/fast' AV nodal reentry tachycardia. Europace. 2000;2(1):15–19
  142. Kalbfleisch SJ, Strickberger SA, Williamson B, et al. Randomized comparison of anatomic and electrogram mapping approaches to ablation of the slow pathway of atrioventricular node reentrant tachycardia. J Am Coll Cardiol. 1994;23(3):716–723
  143. Thibault B, de Bakker JM, Hocini M, et al. Origin of heat-induced accelerated junctional rhythm. J Cardiovasc Electrophysiol. 1998;9(6):631–641
  144. McGavigan AD, Rae AP, Cobbe SM, et al. Junctional rhythm—a suitable surrogate endpoint in catheter ablation of atrioventricular nodal reentry tachycardia?. Pacing Clin Electrophysiol. 2005;28(10):1052–1054
  145. Lipscomb KJ, Zaidi AM, Fitzpatrick AP, et al. Slow pathway modification for atrioventricular node re-entrant tachycardia: fast junctional tachycardia predicts adverse prognosis. Heart (Br Cardiac Soc). 2001;85(1):44–47
  146. Jentzer JH, Goyal R, Williamson BD, et al. Analysis of junctional ectopy during radiofrequency ablation of the slow pathway in patients with atrioventricular nodal reentrant tachycardia. Circulation. 1994;90(6):2820–2826
  147. Thakur RK, Klein GJ, Yee R, et al. Junctional tachycardia: a useful marker during radiofrequency ablation for atrioventricular node reentrant tachycardia. J Am Coll Cardiol. 1993;22(6):1706–1710
  148. Schumacher B, Tebbenjohanns J, Pfeiffer D, et al. Junctional arrhythmias in radiofrequency modification of the atrioventricular node. Z Kardiol. 1995;84(12):977–985
  149. Hintringer F, Hartikainen J, Davies DW, et al. Prediction of atrioventricular block during radiofrequency ablation of the slow pathway of the atrioventricular node. Circulation. 1995;92(12):3490–3496
  150. Kawaguchi N, Kobayashi Y, Miyauchi Y, et al. Incidence and clinical significance of junctional rhythm remaining after termination of radiofrequency current delivery in patients with atrioventricular nodal reentrant tachycardia. Jpn Circulation J. 1999;63(11):865–872
  151. Manolis AS, Maounis T, Vassilikos V, et al. Arrhythmia recurrences are rare when the site of radiofrequency ablation of the slow pathway is medial or anterior to the coronary sinus os. Europace. 2002;4(2):193–199
  152. Manolis AS, Wang PJ, Estes NA. Radiofrequency ablation of slow pathway in patients with atrioventricular nodal reentrant tachycardia (Do arrhythmia recurrences correlate with persistent slow pathway conduction or site of successful ablation?). Circulation. 1994;90(6):2815–2819
  153. Baker JH, Plumb VJ, Epstein AE, et al. Predictors of recurrent atrioventricular nodal reentry after selective slow pathway ablation. Am J Cardiol. 1994;73(11):765–769
  154. Li HG, Klein GJ, Stites HW, et al. Elimination of slow pathway conduction: an accurate indicator of clinical success after radiofrequency atrioventricular node modification. J Am Coll Cardiol. 1993;22(7):1849–1853
  155. Tondo C, Bella PD, Carbucicchio C, et al. Persistence of single echo beat inducibility after selective ablation of the slow pathway in patients with atrioventricular nodal reentrant tachycardia: relationship to the functional properties of the atrioventricular node and clinical implications. J Cardiovasc Electrophysiol. 1996;7(8):689–696
  156. Bogun F, Knight B, Weiss R, et al. Slow pathway ablation in patients with documented but noninducible paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 1996;28(4):1000–1004
  157. Lin JL, Stephen Huang SK, Lai LP, et al. Clinical and electrophysiologic characteristics and long-term efficacy of slow-pathway catheter ablation in patients with spontaneous supraventricular tachycardia and dual atrioventricular node pathways without inducible tachycardia. J Am Coll Cardiol. 1998;31(4):855–860
  158. Moreira JM, Curimbaba J, Filho HC, et al. Persistent inappropriate sinus tachycardia after radiofrequency ablation of left lateral accessory pathway. J Cardiovasc Electrophysiol. 2006;17(6):678–681
  159. Friedman PL, Stevenson WG, Kocovic DZ. Autonomic dysfunction after catheter ablation. J Cardiovasc Electrophysiol. 1996;7(5):450–459
  160. Ehlert FA, Goldberger JJ, Brooks R, et al. Persistent inappropriate sinus tachycardia after radiofrequency current catheter modification of the atrioventricular node. Am J Cardiol. 1992;69(12):1092–1095
  161. Kocovic DZ, Harada T, Shea JB, et al. Alterations of heart rate and of heart rate variability after radiofrequency catheter ablation of supraventricular tachycardia (Delineation of parasympathetic pathways in the human heart). Circulation. 1993;88(4 Pt. 1):1671–1681
  162. Psychari SN, Theodorakis GN, Koutelou M, et al. Cardiac denervation after radiofrequency ablation of supraventricular tachycardias. Am J Cardiol. 1998;81(6):725–731
  163. Li YG, Gronefeld G, Bender B, et al. Risk of development of delayed atrioventricular block after slow pathway modification in patients with atrioventricular nodal reentrant tachycardia and a pre-existing prolonged PR interval. Eur Heart J. 2001;22(1):89–95
  164. Reithmann C, Hoffmann E, Grunewald A, et al. Fast pathway ablation in patients with common atrioventricular nodal reentrant tachycardia and prolonged PR interval during sinus rhythm. Eur Heart J. 1998;19(6):929–935
  165. Rigden LB, Klein LS, Mitrani RD, et al. Increased risk of heart block following slow pathway ablation for AV nodal reentrant tachycardia in patients with marked PR interval prolongation. Pacing Clin Electrophysiol. 1995;18:II-918;(NASPE abstract)
  166. Reithmann C, Remp T, Oversohl N, et al. Ablation for atrioventricular nodal reentrant tachycardia with a prolonged PR interval during sinus rhythm: the risk of delayed higher-degree atrioventricular block. J Cardiovasc Electrophysiol. 2006;17(9):973–979
  167. Sra JS, Jazayeri MR, Blanck Z, et al. Slow pathway ablation in patients with atrioventricular node reentrant tachycardia and a prolonged PR interval. J Am Coll Cardiol. 1994;24(4):1064–1068
  168. Lee SH, Chen SA, Tai CT, et al. Atrioventricular node reentrant tachycardia in patients with a prolonged AH interval during sinus rhythm: clinical features, electrophysiologic characteristics and results of radiofrequency ablation. J Interv Card Electrophysiol. 1997;1(4):305–310
  169. Wang L, Li J, Yao R, et al. Long-term follow-up of patients with P-R prolongation after catheter ablation of slow pathway for atrioventricular node re-entrant tachycardia. Arch Med Res. 2004;35(5):442–445
  170. Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart (In vitro and in vivo accuracy results). Circulation. 1997;95(6):1611–1622
  171. Ben-Haim SA, Osadchy D, Schuster I, et al. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med. 1996;2(12):1393–1395
  172. Wittkampf FH, Wever EF, Derksen R, et al. Accuracy of the LocaLisa system in catheter ablation procedures. J Electrocardiol. 1999;32(suppl):7–12
  173. Kirchhof P, Loh P, Eckardt L, et al. A novel nonfluoroscopic catheter visualization system (LocaLisa) to reduce radiation exposure during catheter ablation of supraventricular tachycardias. Am J Cardiol. 2002;90(3):340–343
  174. Kowalski O, Pruszkowska-Skrzep P, Lenarczyk R, et al. Use of the LocaLisa mapping system during ablation procedures in patients with atrioventricular nodal reentrant tachycardia. Kardiologia polska. 2006;64(6):567–571discussion 572
  175. Schreieck J, Ndrepepa G, Zrenner B, et al. Radiofrequency ablation of cardiac arrhythmias using a three-dimensional real-time position management and mapping system. Pacing Clin Electrophysiol. 2002;25(12):1699–1707
  176. de Groot NM, Bootsma M, van der Velde ET, et al. Three-dimensional catheter positioning during radiofrequency ablation in patients: first application of a real-time position management system. J Cardiovasc Electrophysiol. 2000;11(11):1183–1192
  177. Gornick CC, Adler SW, Pederson B, et al. Validation of a new noncontact catheter system for electroanatomic mapping of left ventricular endocardium. Circulation. 1999;99(6):829–835
  178. Liu X, Wang XH, Gu JN, et al. Electroanatomical systems to guided circumferential pulmonary veins ablation for atrial fibrillation: initial experience from comparison between the Ensite/NavX and CARTO system. Chin Med J (Engl). 2005;118(14):1156–1160
  179. Lustgarten DL, Keane D, Ruskin J. Cryothermal ablation: mechanism of tissue injury and current experience in the treatment of tachyarrhythmias. Prog Cardiovasc Dis. 1999;41(6):481–498
  180. Friedman PL, Dubuc M, Green MS, et al. Catheter cryoablation of supraventricular tachycardia: results of the multicenter prospective “frosty” trial. Heart Rhythm. 2004;1(2):129–138
  181. Skanes AC, Dubuc M, Klein GJ, et al. Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation. 2000;102(23):2856–2860
  182. Collins KK, Dubin AM, Chiesa NA, et al. Cryoablation versus radiofrequency ablation for treatment of pediatric atrioventricular nodal reentrant tachycardia: initial experience with 4-mm cryocatheter. Heart Rhythm. 2006;3(5):564–570
  183. Gupta D, Al-Lamee RK, Earley MJ, et al. Cryoablation compared with radiofrequency ablation for atrioventricular nodal re-entrant tachycardia: analysis of factors contributing to acute and follow-up outcome. Europace. 2006;8(12):1022–1026
  184. Faddis MN, Chen J, Osborn J, et al. Magnetic guidance system for cardiac electrophysiology: a prospective trial of safety and efficacy in humans. J Am Coll Cardiol. 2003;42(11):1952–1958
  185. Kerzner R, Sanchez JM, Osborn JL, et al. Radiofrequency ablation of atrioventricular nodal reentrant tachycardia using a novel magnetic guidance system compared with a conventional approach. Heart Rhythm. 2006;3(3):261–267
  186. Hurwitz JL, German LD, Packer DL, et al. Occurrence of atrial fibrillation in patients with paroxysmal supraventricular tachycardia due to atrioventricular nodal reentry. Pacing Clin Electrophysiol. 1990;13(6):705–710
  187. Razavi M, Cheng J, Rasekh A, et al. Slow pathway ablation decreases vulnerability to pacing-induced atrial fibrillation: possible role of vagal denervation. Pacing Clin Electrophysiol. 2006;29(11):1234–1239
  188. Sauer WH, Alonso C, Zado E, et al. Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: response to ablation that incorporates slow-pathway modification. Circulation. 2006;114(3):191–195
  189. Chen J, Josephson ME. Atrioventricular nodal tachycardia occurring during atrial fibrillation. J Cardiovasc Electrophysiol. 2000;11(7):812–815
  190. Ohnell RF. Pre-excitation, a cardiac abnormality, pathophysiologic, patho-anatomical and clinical studies of excitatory spread phenomenon bearing upon the problem of the WPW (Wolff, Parkinson, and White) electrocardiogram and paroxysmal tachycardia. Acta Med Scand. 1944;152:1–167
  191. Cohn AE, Fraser FR. Paroxysmal tachycardia and the effect of stimulation of the vagus nerve by pressure. Heart (Br Cardiac Soc). 1913;5:93–105
  192. Wilson FN. A case in which the vagus influenced the form of the ventricular complex of the electrogram. Arch Intern Med. 1915;16:1008–1027
  193. Webb AM. Paroxysmal tachycardia with reference to nomotopic tachycardia and the role of the extrinsic cardiac nerves. Arch Intern Med. 1921;27:571–590
  194. Bain CWC, Hamilton CK. Electrocardiographic changes in rheumatic fever. Lancet. 1926;807–809
  195. Bach F. Paroxysmal tachycardia of forty-eight years' duration adn right bundle branch block. Proc R Soc Med. 1929;22:412–414
  196. Hamburger WW. Bundle branch block (Four cases of intravascular block showing some interesting and unusual clinical features). Med Clin North Am. 1929;13:343–362
  197. Wolff L, Parkinson J, White PD. Bundle-branch block with short P-R interval in healthy young people prone to parysmal tachycardia. Am Heart J. 1930;5:685–704
  198. Scheinman MM. History of Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol. 2005;28(2):152–156
  199. Kent AFS. Researches on the structure and function of the mammalian heart. J Physiol. 1893;14:233–254
  200. Holzmann M, Scherf D. Uber Elecktrokardiogramme mit verkurtzer Vorhof-Kammerdiztanz und positiven P-Zacken. Z Klin Med. 1932;121:404–423
  201. Wolferth CC, Wood FC. The mechanism of production of short P-R interval and prolonged QRS complexes in patients with presumably undamaged hearts; hypothesis of an accessory pathway of auriculo-ventricular conduction (bundle of Kent). Am Heart J. 1933;8:297–311
  202. Mahaim I. Kent's fibers and the A-V paraspecific conduction through the upper connections of the bundle of His-Tawara. Am Heart J. 1947;33:651–653
  203. Wood FC, Wolferth CC, Geckeler GD. Histologic demonstration of accessory muscular connections between auricle and ventricle in a case of short P-R interval and prolonged QRS complex. Am Heart J. 1943;25:454–462
  204. James TN. Morphology of the human atrioventricular node with remarks pertinent to its electrophysiology. Am Heart J. 1961;62:756–761
  205. Lev M. Anatomic consideration of anomalous AV pathways. In:  Dreifus LS,  Likoff W editor. Cardiac Arrhythmias. New York: Grune & Stratton; 1966;p. 665–670
  206. Wellens HJ, Schuilenberg RM, Durrer D. Electrical stimulation of the heart in patients with Wolff-Parkinson-White syndrome, type A. Circulation. 1971;43(1):99–114
  207. Gallagher JJ, Pritchett EL, Sealy WC, et al. The preexcitation syndromes. Prog Cardiovasc Dis. 1978;20(4):285–327
  208. Jackman WM, Friday KJ, Scherlag BJ, et al. Direct endocardial recording from an accessory atrioventricular pathway: localization of the site of block, effect of antiarrhythmic drugs, and attempt at nonsurgical ablation. Circulation. 1983;68(5):906–916
  209. Durrer D, Roos JP. Epicardial excitation of the ventricles in a patient with Wolff-Parkinson-White syndrome (type B). Circulation. 1967;35(1):15–21
  210. Burchell HB, Frye RL, Anderson MW, et al. Atrioventricular and ventriculoatrial excitation in Wolff-Parkinson-White syndrome (type B) (Temporary ablation at surgery). Circulation. 1967;36(5):663–672
  211. Iwa T, Kazui T, Sugii S, et al. Surgical treatment of Wolff-Parkinson-White syndrome. Kyobu geka. 1970;23(7):513–518
  212. Morady F, Scheinman MM. Transvenous catheter ablation of a posteroseptal accessory pathway in a patient with the Wolff-Parkinson-White syndrome. N Engl J Med. 1984;310(11):705–707
  213. Schluter M, Geiger M, Siebels J, et al. Catheter ablation using radiofrequency current to cure symptomatic patients with tachyarrhythmias related to an accessory atrioventricular pathway. Circulation. 1991;84(4):1644–1661
  214. Kuck KH, Schluter M, Geiger M, et al. Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet. 1991;337(8757):1557–1561
  215. Calkins H, Sousa J, el-Atassi R, et al. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med. 1991;324(23):1612–1618
  216. Flensted-Jensen E. Wolff-Parkinson-White syndrome: a long-term follow-up of 47 cases. Acta Med Scand. 1969;186:65–74
  217. Dreifus LS, Haiat R, Watanabe Y, et al. Ventricular fibrillation (A possible mechanism of sudden death in patients and Wolff-Parkinson-White syndrome). Circulation. 1971;43(4):520–527
  218. Niksch AL, Dubin AM. Risk stratification in the asymptomatic child with Wolff-Parkinson-White syndrome. Current Opin Cardiol. 2006;21(3):205–207
  219. Fitzsimmons PJ, McWhirter PD, Peterson DW, et al. The natural history of Wolff-Parkinson-White syndrome in 228 military aviators: a long-term follow-up of 22 years. Am Heart J. 2001;142(3):530–536
  220. Berkman NL, Lamb LE. The Wolff-Parkinson-White electrocardiogram (A follow-up study of five to twenty-eight years). N Engl J Med. 1968;278(9):492–494
  221. Orinius E. Pre-excitation: studies on criteria, prognosis, and heredity. Acta Med Scand Suppl. 1966;465:1–55
  222. Deal BJ, Dick M, Beerman L, et al. Cardiac arrest in young patients with Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol. 1995;18(Part II):815
  223. Pappone C, Santinelli V, Manguso F, et al. A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med. 2003;349(19):1803–1811
  224. Pappone C, Manguso F, Santinelli R, et al. Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome. N Engl J Med. 2004;351(12):1197–1205
  225. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary (A report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society). J Am Coll Cardiol. 2003;42(8):1493–1531
  226. Becker AE, Anderson RH, Durrer D, et al. The anatomical substrates of wolff-parkinson-white syndrome (A clinicopathologic correlation in seven patients). Circulation. 1978;57(5):870–879
  227. Peters NS, Rowland E, Bennett JG, et al. The Wolff-Parkinson-White syndrome: the cellular substrate for conduction in the accessory atrioventricular pathway. Eur Heart J. 1994;15(7):981–987
  228. Wellens HJ, Atie J, Penn OC, et al. Diagnosis and treatment of patients with accessory pathways. Cardiol Clin. 1990;8(3):503–521
  229. Li HG, Yee R, Klein GJ. Effect of isoproterenol on accessory pathways without overt retrograde conduction. J Cardiovasc Electrophysiol. 1995;6(3):170–173
  230. Belhassen B, Fish R, Viskin S, et al. Adenosine-5′-triphosphate test for the noninvasive diagnosis of concealed accessory pathway. J Am Coll Cardiol. 2000;36(3):803–810
  231. Belhassen B, Shoshani D, Laniado S. Unmasking of ventricular preexcitation by adenosine triphosphate: its usefulness in the assessment of ajmaline test. Am Heart J. 1989;118(3):634–636
  232. Fitzpatrick AP, Gonzales RP, Lesh MD, et al. New algorithm for the localization of accessory atrioventricular connections using a baseline electrocardiogram. J Am Coll Cardiol. 1994;23(1):107–116
  233. Arruda MS, McClelland JH, Wang X, et al. Development and validation of an ECG algorithm for identifying accessory pathway ablation site in Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol. 1998;9(1):2–12
  234. Xie B, Heald SC, Bashir Y, et al. Localization of accessory pathways from the 12-lead electrocardiogram using a new algorithm. Am J Cardiol. 1994;74(2):161–165
  235. Epstein AE, Kirklin JK, Holman WL, et al. Intermediate septal accessory pathways: electrocardiographic characteristics, electrophysiologic observations and their surgical implications. J Am Coll Cardiol. 1991;17(7):1570–1578
  236. Milstein S, Sharma AD, Guiraudon GM, et al. An algorithm for the electrocardiographic localization of accessory pathways in the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol. 1987;10(3 Pt. 1):555–563
  237. Gallagher JJ, Svenson RH, Sealy WC, et al. The Wolff-Parkinson-White syndrome and the preexcitation dysrhythmias (Medical and surgical management). Med Clin North Am. 1976;60(1):101–123
  238. Yuan S, Iwa T, Tsubota M, et al. Comparative study of eight sets of ECG criteria for the localization of the accessory pathway in Wolff-Parkinson-White syndrome. J Electrocardiol. 1992;25(3):203–214
  239. Fontaine G, Frank R, Coutte R, et al. Rythme reciproue antridromique dans un symdrome de Wolff-Parkinson-White de Type A. Ann Cardiol Angeiol (Paris). 1975;24:59
  240. Prystowsky EN. Diagnosis and management of the preexcitation syndromes. Curr Probl Cardiol. 1988;13(4):225–310
  241. Atie J, Brugada P, Brugada J, et al. Clinical and electrophysiologic characteristics of patients with antidromic circus movement tachycardia in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1990;66(15):1082–1091
  242. Klein GJ, Yee R, Sharma AD. Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern. N Engl J Med. 1989;320(19):1229–1233
  243. Klein GJ, Gulamhusein SS. Intermittent preexcitation in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1983;52(3):292–296
  244. Easley AR, Sensecqua JE, Mann DE, et al. Intermittent preexcitation: marked enhancement of anterograde conduction in the atrioventricular accessory pathway with isoproterenol. Pacing Clin Electrophysiol. 1988;11(3):349–354
  245. Gaita F, Giustetto C, Riccardi R, et al. Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. Am J Cardiol. 1989;64(8):487–490
  246. Daubert C, Ollitrault J, Descaves C, et al. Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff Parkinson White syndrome. Pacing Clin Electrophysiol. 1988;11(8):1130–1138
  247. Eshchar Y, Belhassen B, Laniado S. Comparison of exercise and ajmaline tests with electrophysiologic study in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1986;57(10):782–786
  248. German LD, Gallagher JJ, Broughton A, et al. Effects of exercise and isoproterenol during atrial fibrillation in patients with Wolff-Parkinson-White syndrome. Am J Cardiol. 1983;51(7):1203–1206
  249. Levy S, Broustet JP, Clementy J, et al. [Wolff-Parkinson-White syndrome. Correlation between the results of electrophysiological investigation and exercise tolerance testing on the electrical aspect of preexcitation]. Arch Mal Coeur Vaiss. 1979;72(6):634–640
  250. Wellens HJ, Braat S, Brugada P, et al. Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway. Am J Cardiol. 1982;50(5):1087–1089
  251. Wellens HJ, Bar FW, Gorgels AP, et al. Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathway. Am J Cardiol. 1980;45(1):130–133
  252. Campbell RM, Strieper MJ, Frias PA, et al. Survey of current practice of pediatric electrophysiologists for asymptomatic Wolff-Parkinson-White syndrome. Pediatrics. 2003;111(3):e245–e247
  253. Sarubbi B, D'Alto M, Vergara P, et al. Electrophysiological evaluation of asymptomatic ventricular pre-excitation in children and adolescents. Int J Cardiol. 2005;98(2):207–214
  254. Sarubbi B, Scognamiglio G, Limongelli G, et al. Asymptomatic ventricular pre-excitation in children and adolescents: a 15 year follow up study. Heart (Br Cardiac Soc). 2003;89(2):215–217
  255. Todd DM, Klein GJ, Krahn AD, et al. Asymptomatic Wolff-Parkinson-White syndrome: is it time to revisit guidelines?. J Am Coll Cardiol. 2003;41(2):245–248
  256. Pappone C, Santinelli V, Rosanio S, et al. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol. 2003;41(2):239–244
  257. Milstein S, Sharma AD, Klein GJ. Electrophysiologic profile of asymptomatic Wolff-Parkinson-White pattern. Am J Cardiol. 1986;57(13):1097–1100
  258. Satoh M, Aizawa Y, Funazaki T, et al. Electrophysiologic evaluation of asymptomatic patients with the Wolff-Parkinson-White pattern. Pacing Clin Electrophysiol. 1989;12(3):413–420
  259. Auricchio A, Klein H, Trappe HJ, et al. Lack of prognostic value of syncope in patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1991;17(1):152–158
  260. Paul T, Guccione P, Garson A. Relation of syncope in young patients with Wolff-Parkinson-White syndrome to rapid ventricular response during atrial fibrillation. Am J Cardiol. 1990;65(5):318–321
  261. Steinbeck G. Should radiofrequency current ablation be performed in asymptomatic patients with the Wolff-Parkinson-White syndrome?. Pacing Clin Electrophysiol. 1993;16(3 Pt. 2):649–652
  262. Wellens HJ. Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? (When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram). Circulation. 2005;112(14):2201–2207discussion 2216
  263. Pappone C, Santinelli V. Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? (Catheter ablation should be performed in asymptomatic patients with Wolff-Parkinson-White syndrome). Circulation. 2005;112(14):2207–2215discussion 2216
  264. Jackman WM, Friday KJ, Fitzgerald DM, et al. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia. Am J Cardiol. 1988;62(19):8L–19L
  265. Mandel WJ, Laks MM, Obayashi K, et al. The Wolff-Parkinson-White syndrome: pharmacologic effects of procaine amide. Am Heart J. 1975;90(6):744–754
  266. Hamer AW, Arkles LB, Johns JA. Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. J Am Coll Cardiol. 1989;14(7):1768–1774
  267. Mason JW. Amiodarone. N Engl J Med. 1987;316(8):455–466
  268. Mitchell LB, Wyse DG, Duff HJ. Electropharmacology of sotalol in patients with Wolff-Parkinson-White syndrome. Circulation. 1987;76(4):810–818
  269. Kunze KP, Schluter M, Kuck KH. Sotalol in patients with Wolff-Parkinson-White syndrome. Circulation. 1987;75(5):1050–1057
  270. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis. 1989;32(1):73–97
  271. Wellens HJ. The wide QRS tachycardia. Ann Intern Med. 1986;104(6):879
  272. Calkins H, Kim YN, Schmaltz S, et al. Electrogram criteria for identification of appropriate target sites for radiofrequency catheter ablation of accessory atrioventricular connections. Circulation. 1992;85(2):565–573
  273. Chen X, Borggrefe M, Shenasa M, et al. Characteristics of local electrogram predicting successful transcatheter radiofrequency ablation of left-sided accessory pathways. J Am Coll Cardiol. 1992;20(3):656–665
  274. Lesh MD, Van Hare GF, Scheinman MM, et al. Comparison of the retrograde and transseptal methods for ablation of left free wall accessory pathways. J Am Coll Cardiol. 1993;22(2):542–549
  275. Manolis AS, Wang PJ, Estes NA. Radiofrequency ablation of left-sided accessory pathways: transaortic versus transseptal approach. Am Heart J. 1994;128(5):896–902
  276. Lesh MD, Coggins DL, Ports TA. Coronary air embolism complicating transseptal radiofrequency ablation of left free-wall accessory pathways. Pacing Clin Electrophysiol. 1992;15(8):1105–1108
  277. Wood MA. Ablation of free wall accessory pathways. In:  Huang SKS,  Wood MA editor. Catheter Ablation of Cardiac Arrhythmias. Philadelphia, PA: Saunders-Elsevier; 2006;p. 371–398
  278. Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial (The Atakr Multicenter Investigators Group). Circulation. 1999;99(2):262–270
  279. Shah MJ, Jones TK, Cecchin F. Improved localization of right-sided accessory pathways with microcatheter-assisted right coronary artery mapping in children. J Cardiovasc Electrophysiol. 2004;15(11):1238–1243
  280. Knilans TK. Multielectrode coronary artery catheterization: still an effective tool in ablation of right free-wall accessory pathways. J Cardiovasc Electrophysiol. 2004;15(11):1244–1245
  281. Lesh MD, Van Hare GF, Chien WW, et al. Mapping in the right coronary artery as an aid to radiofrequency ablation of right-sided accessory pathways [abstract]. Pacing Clin Electrophysiol. 1994;14:671
  282. Kuck KH, Schluter M, Gursoy S. Preservation of atrioventricular nodal conduction during radiofrequency current catheter ablation of midseptal accessory pathways. Circulation. 1992;86(6):1743–1752
  283. Knight BP, Morady F. Catheter ablation of accessory pathways. Cardiol Clin. 1997;15(4):647–660
  284. Skanes AC, Yee R, Krahn AD, et al. Cryoablation of atrial arrhythmias. Card Electrophysiol Rev. 2002;6(4):383–388
  285. Gaita F, Haissaguerre M, Giustetto C, et al. Safety and efficacy of cryoablation of accessory pathways adjacent to the normal conduction system. J Cardiovasc Electrophysiol. 2003;14(8):825–829
  286. Huang H, Wang X, Ouyang F, et al. Catheter ablation of anteroseptal accessory pathway in the non-coronary aortic sinus. Europace. 2006;8(12):1041–1044
  287. Belhassen B, Viskin S, Fish R, et al. Catheter-induced mechanical trauma to accessory pathways during radiofrequency ablation: incidence, predictors and clinical implications. J Am Coll Cardiol. 1999;33(3):767–774
  288. Kuck KH, Ouyang F, Goya M, et al. Ablation of anteroseptal and midseptal accessory pathways. In:  Zipes DP,  Haissaguerre M editor. Catheter Ablation of Arrhythmias. Armonk, NY: Futura; 2002;p. 305–320
  289. Calkins H, Langberg J, Sousa J, et al. Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients (Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome). Circulation. 1992;85(4):1337–1346
  290. Dhala AA, Deshpande SS, Bremner S, et al. Transcatheter ablation of posteroseptal accessory pathways using a venous approach and radiofrequency energy. Circulation. 1994;90(4):1799–1810
  291. Sun Y, Arruda M, Otomo K, et al. Coronary sinus-ventricular accessory connections producing posteroseptal and left posterior accessory pathways: incidence and electrophysiological identification. Circulation. 2002;106(11):1362–1367
  292. Matsuo K, Doi Y, Fukae S, et al. Radiofrequency catheter ablation of a concealed atrioventricular accessory pathway associated with a coronary sinus diverticulum. Jpn Circ J. 2000;64(5):393–395
  293. Beukema WP, Van Dessel PF, Van Hemel NM, et al. Radiofrequency catheter ablation of accessory pathways associated with a coronary sinus diverticulum. Eur Heart J. 1994;15(10):1415–1418
  294. Tebbenjohanns J, Pfeiffer D, Jung W, et al. Radiofrequency catheter ablation of a posteroseptal accessory pathway within a coronary sinus diverticulum. Am Heart J. 1993;126(5):1216–1219
  295. Connelly DT, Rowland E, Ahsan AJ, et al. Low energy catheter ablation of a posteroseptal accessory pathway associated with a diverticulum of the coronary sinus. Pacing Clin Electrophysiol. 1991;14(8):1217–1221
  296. Gupta A, Vora AM, Lokhandwala Y. Coronary sinus diverticulum with a concealed posteroseptal accessory pathway: a red herring?. Indian Heart J. 2001;53(1):97–99
  297. Lesh MD, Van Hare G, Kao AK, et al. Radiofrequency catheter ablation for Wolff-Parkinson-White syndrome associated with a coronary sinus diverticulum. Pacing Clin Electrophysiol. 1991;14(10):1479–1484
  298. Chiang CE, Chen SA, Tai CT, et al. Prediction of successful ablation site of concealed posteroseptal accessory pathways by a novel algorithm using baseline electrophysiological parameters: implication for an abbreviated ablation procedure. Circulation. 1996;93(5):982–991
  299. Gatzoulis KA, Apostolopoulos T, Costeas X, et al. Radiofrequency catheter ablation of posteroseptal accessory pathways—results of a step-by-step ablation approach. J Interv Card Electrophysiol. 2001;5(2):193–201
  300. Wen MS, Yeh SJ, Wang CC, et al. Radiofrequency ablation therapy of the posteroseptal accessory pathway. Am Heart J. 1996;132(3):612–620
  301. Moreira JM, Curimbaba J, Pimenta J. Slow junctional rhythm during catheter ablation of right posteroseptal accessory pathway causing transient atrioventricular block. Pacing Clin Electrophysiol. 2003;26(3):770–772
  302. Schaffer MS, Silka MJ, Ross BA, et al. Inadvertent atrioventricular block during radiofrequency catheter ablation (Results of the Pediatric Radiofrequency Ablation Registry. Pediatric Electrophysiology Society). Circulation. 1996;94(12):3214–3220
  303. Seidl K, Hauer B, Zahn R, et al. Unexpected complete AV block following transcatheter ablation of a left posteroseptal accessory pathway. Pacing Clin Electrophysiol. 1998;21(11 Pt. 1):2139–2142
  304. Liu J, Dole LR. Late complete atrioventricular block complicating radiofrequency catheter ablation of a left posteroseptal accessory pathway. Pacing Clin Electrophysiol. 1998;21(11 Pt. 1):2136–2138
  305. Pelargonio G, Fogel RI, Knilans TK, et al. Late occurrence of heart block after radiofrequency catheter ablation of the septal region: clinical follow-up and outcome. J Cardiovasc Electrophysiol. 2001;12(1):56–60
  306. Langberg JJ, Man KC, Vorperian VR, et al. Recognition and catheter ablation of subepicardial accessory pathways. J Am Coll Cardiol. 1993;22(4):1100–1104
  307. Valderrabano M, Cesario DA, Ji S, et al. Percutaneous epicardial mapping during ablation of difficult accessory pathways as an alternative to cardiac surgery. Heart Rhythm. 2004;1(3):311–316
  308. Morady F, Strickberger A, Man KC, et al. Reasons for prolonged or failed attempts at radiofrequency catheter ablation of accessory pathways. J Am Coll Cardiol. 1996;27(3):683–689
  309. Sung RJ, Castellanos A, Mallon SM, et al. Mechanisms of spontaneous alternation between reciprocating tachycardia and atrial flutter-fibrillation in the Wolff-Parkinson-White syndrome. Circulation. 1977;56(3):409–416
  310. Sharma AD, Klein GJ, Guiraudon GM, et al. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway. Circulation. 1985;72(1):161–169
  311. Campbell RW, Smith RA, Gallagher JJ, et al. Atrial fibrillation in the preexcitation syndrome. Am J Cardiol. 1977;40(4):514–520
  312. Haissaguerre M, Fischer B, Labbe T, et al. Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways. Am J Cardiol. 1992;69(5):493–497
  313. Sakabe K, Fukuda N, Nada T, et al. Atrial electrophysiologic abnormalities in patients with Wolff-Parkinson-White syndrome but without paroxysmal atrial fibrillation. Clin Cardiol. 2004;27(7):396–400
  314. Tsuchioka Y, Karakawa S, Nagata K, et al. The role of the accessory pathway in the onset of atrial fibrillation in Wolff-Parkinson-White syndrome—electrophysiological examination before and after surgical ablation. Jpn Circ J. 1994;58(2):95–99
  315. Waspe LE, Brodman R, Kim SG, et al. Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway. Am Heart J. 1986;112(6):1141–1152
  316. Dagres N, Clague JR, Lottkamp H, et al. Impact of radiofrequency catheter ablation of accessory pathways on the frequency of atrial fibrillation during long-term follow-up; high recurrence rate of atrial fibrillation in patients older than 50 years of age. Eur Heart J. 2001;22(5):423–427
  317. Wang L, Yang H, Zhang Y. Recurrence of symptomatic atrial fibrillation after successful catheter ablation of atrioventricular accessory pathways: a multivariate regression analysis. Int J Clin Pract. 2005;59(8):886–890

 The authors have no conflicts of interest to disclose.

PII: S0146-2806(08)00087-X

doi: 10.1016/j.cpcardiol.2008.06.002

Current Problems in Cardiology
Volume 33, Issue 9 , Pages 467-546 , September 2008

Article Tools

* Image Usage & Resolution